Therapeutic Hypothermia Systems Market by Product (Cooling Devices, Cooling Catheters, Cool Caps), Application (Neurology, Cardiology, Neonatal Care), and Region (North America, Europe, Asia- Pacific, RoW) - Global Forecast to 2028
The global therapeutic hypothermia systems market is projected to reach USD 396 million by 2028 from USD 291 million in 2023, at a CAGR of 6.3% during the forecast period. The growth of this market is majorly driven by the growing prevalence of infectious and chronic diseases and the rise in the use of minimally invasive cooling methods. However, the presence of alternative methods and less awareness in developing countries could restrain the growth of the therapeutic hypothermia systems market.
“Cooling devices segment accounted for the highest market share in the therapeutic hypothermia systems market, by product, during the forecast period.”
Based on product, the therapeutic hypothermia systems market is classified into Cooling Catheters, Cooling devices and Cool Caps. The cooling devices segment dominated the market in 2022. The large share of the segment can be attributed to the ease of use, fewer labor-intensive devices available, and the presence of a simple and effective thermal regulating system with the control unit.
“Cardiology accounted for the highest CAGR during the forecast period.”
Based on the application, the therapeutic hypothermia systems market is segmented into Neurology, Cardiology, Neonatal care, and other applications. The cardiology segment accounted for the highest CAGR of the therapeutic hypothermia systems market in 2022. The highest CAGR of this segment can be primarily attributed to the potential benefit of using hypothermia for treating cardiac arrest patients.
“The North America segment accounted for the highest market share in the therapeutic hypothermia systems market, by region, during the forecast period.”
Based on the region, the global therapeutic hypothermia systems market is categorized into North America, Asia Pacific, Europe, and the Rest of the World. North America is expected to witness a high market share during the forecast period. The presence of technologically advanced therapeutic hypothermia systems products and the increasing advancement in the medical device industries are supporting the growth of the therapeutic hypothermia systems market.
Breakdown of supply-side primary interviews by company type, designation, and region:
Research Coverage
This research report categorizes the therapeutic hypothermia systems market by product, application, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the therapeutic hypothermia systems market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the therapeutic hypothermia systems market. Competitive analysis of upcoming startups in the therapeutic hypothermia systems market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall therapeutic hypothermia systems market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
“Cooling devices segment accounted for the highest market share in the therapeutic hypothermia systems market, by product, during the forecast period.”
Based on product, the therapeutic hypothermia systems market is classified into Cooling Catheters, Cooling devices and Cool Caps. The cooling devices segment dominated the market in 2022. The large share of the segment can be attributed to the ease of use, fewer labor-intensive devices available, and the presence of a simple and effective thermal regulating system with the control unit.
“Cardiology accounted for the highest CAGR during the forecast period.”
Based on the application, the therapeutic hypothermia systems market is segmented into Neurology, Cardiology, Neonatal care, and other applications. The cardiology segment accounted for the highest CAGR of the therapeutic hypothermia systems market in 2022. The highest CAGR of this segment can be primarily attributed to the potential benefit of using hypothermia for treating cardiac arrest patients.
“The North America segment accounted for the highest market share in the therapeutic hypothermia systems market, by region, during the forecast period.”
Based on the region, the global therapeutic hypothermia systems market is categorized into North America, Asia Pacific, Europe, and the Rest of the World. North America is expected to witness a high market share during the forecast period. The presence of technologically advanced therapeutic hypothermia systems products and the increasing advancement in the medical device industries are supporting the growth of the therapeutic hypothermia systems market.
Breakdown of supply-side primary interviews by company type, designation, and region:
- By Company Type: Tier 1 (30%), Tier 2 (48%), and Tier 3 (22%)
- By Designation: C-level (28%), Director-level (33%), and Others (39%)
- By Region: North America (21%), Europe (30%), Asia-Pacific (34%), and RoW (15%)
Research Coverage
This research report categorizes the therapeutic hypothermia systems market by product, application, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the therapeutic hypothermia systems market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the therapeutic hypothermia systems market. Competitive analysis of upcoming startups in the therapeutic hypothermia systems market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall therapeutic hypothermia systems market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the therapeutic hypothermia systems market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the therapeutic hypothermia systems market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the therapeutic hypothermia systems market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the therapeutic hypothermia systems market
- Competitive Assessment: In-depth assessment of market ranking, growth strategies, and service offerings of leading players like ZOLL Medical Corporation (Japan), Becton, Dickinson and Company (US), Stryker Corporation (US), among others in the therapeutic hypothermia systems market strategies.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION
2.2.2 APPROACH 2: NUMBER OF THERAPEUTIC HYPOTHERMIA SYSTEMS
TABLE 1 REVENUE ESTIMATION APPROACH BY CALCULATING MARKET SIZE OF THERAPEUTIC HYPOTHERMIA SYSTEMS
2.2.3 APPROACH 3: PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS
2.2.4 APPROACH 4: PRIMARY INTERVIEWS
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 8 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 MARKET ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT
2.7 RECESSION IMPACT ON THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET
3 EXECUTIVE SUMMARY
FIGURE 10 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 11 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET
4 PREMIUM INSIGHTS
4.1 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET OVERVIEW
FIGURE 13 RISING NUMBER OF SURGICAL PROCEDURES TO DRIVE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET
4.2 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT AND COUNTRY (2022)
FIGURE 14 COOLING DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022
4.3 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 15 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: REGIONAL MIX
FIGURE 16 ASIA PACIFIC MARKET TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD
4.5 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DEVELOPED VS. EMERGING ECONOMIES
FIGURE 17 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising population and increasing prevalence of chronic and infectious diseases
5.2.1.2 Increasing number of surgical procedures
5.2.1.3 Rising number of hypothermia cases
5.2.1.4 Growing number of trauma cases
5.2.1.5 Rising adoption of minimally invasive cooling methods
5.2.1.6 Growing demand for targeted temperature management in cardiac arrest
5.2.2 RESTRAINTS
5.2.2.1 Lack of awareness regarding therapeutic hypothermia systems in developing countries
5.2.2.2 Availability of alternative methods
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing growth opportunities in emerging economies
5.2.3.2 Developing healthcare infrastructure
5.2.3.3 Growing number of contracts and agreements between market players
5.2.4 CHALLENGES
5.2.4.1 Lack of skilled healthcare professionals
5.2.4.2 Lack of proper supply chain management
5.2.4.3 Product recalls
5.3 VALUE CHAIN ANALYSIS
FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
5.4 SUPPLY CHAIN ANALYSIS
FIGURE 20 DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES
5.5 PORTER’S FIVE FORCES ANALYSIS
TABLE 3 PORTER’S FIVE FORCES ANALYSIS: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET
5.5.1 INTENSITY OF COMPETITIVE RIVALRY
5.5.2 BARGAINING POWER OF SUPPLIERS
5.5.3 BARGAINING POWER OF BUYERS
5.5.4 THREAT OF SUBSTITUTES
5.5.5 THREAT OF NEW ENTRANTS
5.6 REGULATORY ANALYSIS
TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THERAPEUTIC HYPOTHERMIA SYSTEMS
5.6.1 NORTH AMERICA
5.6.1.1 US
TABLE 5 CLASSIFICATION OF MEDICAL DEVICES BY US FDA
FIGURE 21 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES
5.6.1.2 Canada
FIGURE 22 CANADA: APPROVAL PROCESS FOR MEDICAL DEVICES
5.6.2 EUROPE
FIGURE 23 CE APPROVAL PROCESS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS
5.6.3 ASIA PACIFIC
5.6.3.1 Japan
TABLE 6 JAPAN: CLASSIFICATION OF MEDICAL DEVICES
5.6.3.2 China
TABLE 7 NMPA MEDICAL DEVICES CLASSIFICATION
5.6.3.3 India
5.7 TRADE ANALYSIS
5.7.1 TRADE ANALYSIS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS
TABLE 8 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 9 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION)
5.8 TECHNOLOGY ANALYSIS
5.9 ECOSYSTEM ANALYSIS
FIGURE 24 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: ECOSYSTEM ANALYSIS
5.9.1 ROLE IN ECOSYSTEM
FIGURE 25 KEY PLAYERS IN THERAPEUTIC HYPOTHERMIA SYSTEMS ECOSYSTEM
5.10 PATENT ANALYSIS
FIGURE 26 PATENT ANALYSIS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS
5.11 KEY CONFERENCES AND EVENTS IN 2024–2025
TABLE 10 LIST OF CONFERENCES AND EVENTS IN 2024–2025
5.12 PRICING ANALYSIS
TABLE 11 AVERAGE SELLING PRICE OF KEY PRODUCTS IN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET (2019–2022)
TABLE 12 AVERAGE SELLING PRICE TRENDS, BY REGION, 2019–2022
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.13.1 REVENUE SHIFT & REVENUE POCKETS FOR THERAPEUTIC HYPOTHERMIA SYSTEM MANUFACTURERS
FIGURE 27 REVENUE SHIFT FOR THERAPEUTIC HYPOTHERMIA SYSTEMS
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS
5.14.2 BUYING CRITERIA
FIGURE 29 KEY BUYING CRITERIA FOR TOP END USERS
TABLE 14 KEY BUYING CRITERIA, BY TOP END USER
6 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 15 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 COOLING DEVICES
6.2.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE DEMAND
TABLE 16 THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 17 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 18 EUROPE: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 19 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 20 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3 COOLING CATHETERS
6.3.1 ABILITY TO COOL SPECIFIC AREAS EFFICIENTLY TO SUPPORT MARKET GROWTH
TABLE 21 THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 22 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 23 EUROPE: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 24 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 25 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.4 COOL CAPS
6.4.1 INCREASING NUMBER OF CHEMOTHERAPY PROCEDURES TO DRIVE DEMAND
TABLE 26 THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 27 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 28 EUROPE: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 29 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 30 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY REGION, 2021–2028 (USD MILLION)
7 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 31 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
7.2 NEUROLOGY
7.2.1 GROWING PREVALENCE OF TBI AND OTHER NEUROLOGICAL DISEASES TO DRIVE MARKET
TABLE 32 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 33 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 34 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 35 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY REGION, 2021–2028 (USD MILLION)
7.3 CARDIOLOGY
7.3.1 HIGH INCIDENCE OF CARDIAC ARRESTS TO SUPPORT MARKET GROWTH
TABLE 37 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 38 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 39 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 40 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 41 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY REGION, 2021–2028 (USD MILLION)
7.4 NEONATAL CARE
7.4.1 INCREASING NUMBER OF PRETERM BIRTHS TO SUPPORT MARKET GROWTH
TABLE 42 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY REGION, 2021–2028 (USD MILLION)
TABLE 43 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 45 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 46 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY REGION, 2021–2028 (USD MILLION)
7.5 OTHER APPLICATIONS
TABLE 47 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 50 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 51 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
8 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY REGION
8.1 INTRODUCTION
TABLE 52 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
8.2 NORTH AMERICA
FIGURE 30 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SNAPSHOT
8.2.1 NORTH AMERICA: RECESSION IMPACT
TABLE 53 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 55 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2.2 US
8.2.2.1 Growing number of cardiac arrest and brain injury cases to support market growth
TABLE 56 US: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 57 US: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 58 US: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)
8.2.3 CANADA
8.2.3.1 Increasing incidence of various chronic diseases to drive market
TABLE 59 CANADA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 60 CANADA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.3 EUROPE
8.3.1 EUROPE: RECESSION IMPACT
TABLE 61 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 63 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.3.2 GERMANY
8.3.2.1 High demand for patient cooling devices for cardiology procedures to drive market
TABLE 64 GERMANY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 65 GERMANY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 66 GERMANY: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)
8.3.3 UK
8.3.3.1 Rising number of sports injuries and accident & emergency procedures to drive market
TABLE 67 UK: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 68 UK: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 69 UK: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)
8.3.4 FRANCE
8.3.4.1 Strong healthcare system to support market growth
TABLE 70 FRANCE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 71 FRANCE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 72 FRANCE: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)
8.3.5 ITALY
8.3.5.1 Growing demand for therapeutic hypothermia systems in traumatic brain injury treatment to support market growth
TABLE 73 ITALY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 74 ITALY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.3.6 SPAIN
8.3.6.1 Growing geriatric population and subsequent increase in prevalence of target conditions to drive market
TABLE 75 SPAIN: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 76 SPAIN: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.3.7 REST OF EUROPE
TABLE 77 REST OF EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 78 REST OF EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.4 ASIA PACIFIC
FIGURE 31 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SNAPSHOT
8.4.1 ASIA PACIFIC: RECESSION IMPACT
TABLE 79 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 81 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.4.2 CHINA
8.4.2.1 Increasing disposable income of middle-class population to drive market
TABLE 82 CHINA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 83 CHINA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 84 CHINA: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)
8.4.3 JAPAN
8.4.3.1 Rapidly increasing geriatric population to drive market
TABLE 85 JAPAN: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 86 JAPAN: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 87 JAPAN: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)
8.4.4 INDIA
8.4.4.1 Growing target patient population to support market growth
TABLE 88 INDIA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 89 INDIA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.4.5 REST OF ASIA PACIFIC
TABLE 90 REST OF ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 91 REST OF ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.5 REST OF THE WORLD
8.5.1 REST OF THE WORLD: RECESSION IMPACT
TABLE 92 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 93 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 94 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.5.2 LATIN AMERICA
8.5.2.1 Rising prevalence of chronic diseases to drive market
TABLE 95 LATIN AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 96 LATIN AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.5.3 MIDDLE EAST & AFRICA
8.5.3.1 High prevalence of chronic conditions to support market growth
TABLE 97 MIDDLE EAST & AFRICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 98 MIDDLE EAST & AFRICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.5.4 GCC COUNTRIES
8.5.4.1 Rise in road accident injuries and TBI to drive market
TABLE 99 GCC COUNTRIES: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 100 GCC COUNTRIES: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 STRATEGIES ADOPTED BY KEY PLAYERS
TABLE 101 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET
9.3 REVENUE ANALYSIS
FIGURE 32 REVENUE ANALYSIS FOR KEY COMPANIES IN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, 2018–2022 (USD MILLION)
9.4 MARKET SHARE ANALYSIS
FIGURE 33 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET RANKING ANALYSIS, BY KEY PLAYER (2022)
TABLE 102 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DEGREE OF COMPETITION
9.5 COMPANY EVALUATION MATRIX
9.5.1 STARS
9.5.2 EMERGING LEADERS
9.5.3 PERVASIVE PLAYERS
9.5.4 PARTICIPANTS
FIGURE 34 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: COMPANY EVALUATION MATRIX, 2022
9.5.5 COMPANY FOOTPRINT
TABLE 103 PRODUCT FOOTPRINT (11 PLAYERS)
TABLE 104 REGIONAL FOOTPRINT (11 PLAYERS)
TABLE 105 OVERALL COMPANY FOOTPRINT (11 PLAYERS)
9.6 STARTUP/SME EVALUATION MATRIX
9.6.1 PROGRESSIVE COMPANIES
9.6.2 STARTING BLOCKS
9.6.3 RESPONSIVE COMPANIES
9.6.4 DYNAMIC COMPANIES
FIGURE 35 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: STARTUP/SME EVALUATION MATRIX, 2022
9.6.5 COMPETITIVE BENCHMARKING
TABLE 106 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 107 PRODUCT & SERVICE FOOTPRINT (STARTUPS/SMES)
TABLE 108 REGIONAL FOOTPRINT (STARTUPS/SMES)
TABLE 109 OVERALL COMPANY FOOTPRINT (STARTUPS/SMES)
9.7 COMPETITIVE SCENARIO AND TRENDS
9.7.1 DEALS
TABLE 110 THERAPEUTIC HYPOTHERMIA SYSTEMS: DEALS, JANUARY 2020–NOVEMBER 2023
9.7.2 OTHER DEVELOPMENTS
TABLE 111 THERAPEUTIC HYPOTHERMIA SYSTEMS: OTHER DEVELOPMENTS, JANUARY 2020–NOVEMBER 2023
10 COMPANY PROFILES
10.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
10.1.1 ASAHI KASEI CORPORATION (ZOLL MEDICAL CORPORATION)
TABLE 112 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW
FIGURE 36 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2022)
10.1.2 BECTON, DICKINSON AND COMPANY
TABLE 113 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 37 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
10.1.3 GENTHERM INCORPORATED
TABLE 114 GENTHERM INCORPORATED: BUSINESS OVERVIEW
FIGURE 38 GENTHERM INCORPORATED: COMPANY SNAPSHOT (2022)
10.1.4 STRYKER CORPORATION
TABLE 115 STRYKER CORPORATION: BUSINESS OVERVIEW
FIGURE 39 STRYKER CORPORATION: COMPANY SNAPSHOT (2022)
10.1.5 BELMONT MEDICAL TECHNOLOGIES
TABLE 116 BELMONT MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW
10.1.6 INTERNATIONAL BIOMEDICAL LTD.
TABLE 117 INTERNATIONAL BIOMEDICAL LTD.: BUSINESS OVERVIEW
10.1.7 EM-MED
TABLE 118 EM-MED: BUSINESS OVERVIEW
10.1.8 PHOENIX MEDICAL SYSTEMS
TABLE 119 PHOENIX MEDICAL SYSTEMS: BUSINESS OVERVIEW
10.1.9 LIFE RECOVERY SYSTEMS
TABLE 120 LIFE RECOVERY SYSTEMS: BUSINESS OVERVIEW
10.1.10 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.
TABLE 121 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.: BUSINESS OVERVIEW
10.1.11 MIRACRADLE (PLUSS ADVANCED TECHNOLOGIES PVT. LTD.)
TABLE 122 MIRACRADLE: BUSINESS OVERVIEW
10.2 OTHER PLAYERS
10.2.1 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
TABLE 123 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: COMPANY OVERVIEW
10.2.2 PFM MEDICAL HICO GMBH
TABLE 124 PFM MEDICAL HICO GMBH: COMPANY OVERVIEW
10.2.3 VNG MEDICAL INNOVATION SYSTEM PVT. LTD.
TABLE 125 VNG MEDICAL INNOVATION SYSTEM PVT. LTD.: COMPANY OVERVIEW
10.2.4 ASPEN SYSTEMS
TABLE 126 ASPEN SYSTEMS: COMPANY OVERVIEW
10.2.5 COOLTECH MEDICAL
TABLE 127 COOLTECH MEDICAL: COMPANY OVERVIEW
10.2.6 GLOBAL HEALTHCARE SG
TABLE 128 GLOBAL HEALTHCARE SG: COMPANY OVERVIEW
10.2.7 CRYOTHERMIC SYSTEMS INCORPORATED
TABLE 129 CRYOTHERMIC SYSTEMS INCORPORATED: COMPANY OVERVIEW
10.2.8 PAXMAN COOLERS LTD.
TABLE 130 PAXMAN COOLERS LTD.: COMPANY OVERVIEW
10.2.9 DIGNITANA AB
TABLE 131 DIGNITANA AB: COMPANY OVERVIEW
10.2.10 WISHCAPS
TABLE 132 WISHCAPS: COMPANY OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11 APPENDIX
11.1 DISCUSSION GUIDE
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.3 CUSTOMIZATION OPTIONS
11.4 RELATED REPORTS
11.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION
2.2.2 APPROACH 2: NUMBER OF THERAPEUTIC HYPOTHERMIA SYSTEMS
TABLE 1 REVENUE ESTIMATION APPROACH BY CALCULATING MARKET SIZE OF THERAPEUTIC HYPOTHERMIA SYSTEMS
2.2.3 APPROACH 3: PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS
2.2.4 APPROACH 4: PRIMARY INTERVIEWS
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 8 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 MARKET ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT
2.7 RECESSION IMPACT ON THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET
3 EXECUTIVE SUMMARY
FIGURE 10 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 11 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET
4 PREMIUM INSIGHTS
4.1 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET OVERVIEW
FIGURE 13 RISING NUMBER OF SURGICAL PROCEDURES TO DRIVE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET
4.2 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT AND COUNTRY (2022)
FIGURE 14 COOLING DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022
4.3 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 15 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: REGIONAL MIX
FIGURE 16 ASIA PACIFIC MARKET TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD
4.5 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DEVELOPED VS. EMERGING ECONOMIES
FIGURE 17 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising population and increasing prevalence of chronic and infectious diseases
5.2.1.2 Increasing number of surgical procedures
5.2.1.3 Rising number of hypothermia cases
5.2.1.4 Growing number of trauma cases
5.2.1.5 Rising adoption of minimally invasive cooling methods
5.2.1.6 Growing demand for targeted temperature management in cardiac arrest
5.2.2 RESTRAINTS
5.2.2.1 Lack of awareness regarding therapeutic hypothermia systems in developing countries
5.2.2.2 Availability of alternative methods
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing growth opportunities in emerging economies
5.2.3.2 Developing healthcare infrastructure
5.2.3.3 Growing number of contracts and agreements between market players
5.2.4 CHALLENGES
5.2.4.1 Lack of skilled healthcare professionals
5.2.4.2 Lack of proper supply chain management
5.2.4.3 Product recalls
5.3 VALUE CHAIN ANALYSIS
FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
5.4 SUPPLY CHAIN ANALYSIS
FIGURE 20 DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES
5.5 PORTER’S FIVE FORCES ANALYSIS
TABLE 3 PORTER’S FIVE FORCES ANALYSIS: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET
5.5.1 INTENSITY OF COMPETITIVE RIVALRY
5.5.2 BARGAINING POWER OF SUPPLIERS
5.5.3 BARGAINING POWER OF BUYERS
5.5.4 THREAT OF SUBSTITUTES
5.5.5 THREAT OF NEW ENTRANTS
5.6 REGULATORY ANALYSIS
TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THERAPEUTIC HYPOTHERMIA SYSTEMS
5.6.1 NORTH AMERICA
5.6.1.1 US
TABLE 5 CLASSIFICATION OF MEDICAL DEVICES BY US FDA
FIGURE 21 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES
5.6.1.2 Canada
FIGURE 22 CANADA: APPROVAL PROCESS FOR MEDICAL DEVICES
5.6.2 EUROPE
FIGURE 23 CE APPROVAL PROCESS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS
5.6.3 ASIA PACIFIC
5.6.3.1 Japan
TABLE 6 JAPAN: CLASSIFICATION OF MEDICAL DEVICES
5.6.3.2 China
TABLE 7 NMPA MEDICAL DEVICES CLASSIFICATION
5.6.3.3 India
5.7 TRADE ANALYSIS
5.7.1 TRADE ANALYSIS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS
TABLE 8 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 9 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION)
5.8 TECHNOLOGY ANALYSIS
5.9 ECOSYSTEM ANALYSIS
FIGURE 24 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: ECOSYSTEM ANALYSIS
5.9.1 ROLE IN ECOSYSTEM
FIGURE 25 KEY PLAYERS IN THERAPEUTIC HYPOTHERMIA SYSTEMS ECOSYSTEM
5.10 PATENT ANALYSIS
FIGURE 26 PATENT ANALYSIS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS
5.11 KEY CONFERENCES AND EVENTS IN 2024–2025
TABLE 10 LIST OF CONFERENCES AND EVENTS IN 2024–2025
5.12 PRICING ANALYSIS
TABLE 11 AVERAGE SELLING PRICE OF KEY PRODUCTS IN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET (2019–2022)
TABLE 12 AVERAGE SELLING PRICE TRENDS, BY REGION, 2019–2022
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.13.1 REVENUE SHIFT & REVENUE POCKETS FOR THERAPEUTIC HYPOTHERMIA SYSTEM MANUFACTURERS
FIGURE 27 REVENUE SHIFT FOR THERAPEUTIC HYPOTHERMIA SYSTEMS
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS
5.14.2 BUYING CRITERIA
FIGURE 29 KEY BUYING CRITERIA FOR TOP END USERS
TABLE 14 KEY BUYING CRITERIA, BY TOP END USER
6 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 15 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 COOLING DEVICES
6.2.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE DEMAND
TABLE 16 THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 17 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 18 EUROPE: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 19 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 20 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3 COOLING CATHETERS
6.3.1 ABILITY TO COOL SPECIFIC AREAS EFFICIENTLY TO SUPPORT MARKET GROWTH
TABLE 21 THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 22 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 23 EUROPE: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 24 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 25 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.4 COOL CAPS
6.4.1 INCREASING NUMBER OF CHEMOTHERAPY PROCEDURES TO DRIVE DEMAND
TABLE 26 THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 27 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 28 EUROPE: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 29 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 30 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY REGION, 2021–2028 (USD MILLION)
7 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 31 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
7.2 NEUROLOGY
7.2.1 GROWING PREVALENCE OF TBI AND OTHER NEUROLOGICAL DISEASES TO DRIVE MARKET
TABLE 32 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 33 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 34 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 35 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY REGION, 2021–2028 (USD MILLION)
7.3 CARDIOLOGY
7.3.1 HIGH INCIDENCE OF CARDIAC ARRESTS TO SUPPORT MARKET GROWTH
TABLE 37 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 38 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 39 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 40 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 41 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY REGION, 2021–2028 (USD MILLION)
7.4 NEONATAL CARE
7.4.1 INCREASING NUMBER OF PRETERM BIRTHS TO SUPPORT MARKET GROWTH
TABLE 42 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY REGION, 2021–2028 (USD MILLION)
TABLE 43 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 45 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 46 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY REGION, 2021–2028 (USD MILLION)
7.5 OTHER APPLICATIONS
TABLE 47 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 50 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 51 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
8 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY REGION
8.1 INTRODUCTION
TABLE 52 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
8.2 NORTH AMERICA
FIGURE 30 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SNAPSHOT
8.2.1 NORTH AMERICA: RECESSION IMPACT
TABLE 53 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 55 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2.2 US
8.2.2.1 Growing number of cardiac arrest and brain injury cases to support market growth
TABLE 56 US: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 57 US: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 58 US: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)
8.2.3 CANADA
8.2.3.1 Increasing incidence of various chronic diseases to drive market
TABLE 59 CANADA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 60 CANADA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.3 EUROPE
8.3.1 EUROPE: RECESSION IMPACT
TABLE 61 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 63 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.3.2 GERMANY
8.3.2.1 High demand for patient cooling devices for cardiology procedures to drive market
TABLE 64 GERMANY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 65 GERMANY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 66 GERMANY: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)
8.3.3 UK
8.3.3.1 Rising number of sports injuries and accident & emergency procedures to drive market
TABLE 67 UK: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 68 UK: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 69 UK: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)
8.3.4 FRANCE
8.3.4.1 Strong healthcare system to support market growth
TABLE 70 FRANCE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 71 FRANCE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 72 FRANCE: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)
8.3.5 ITALY
8.3.5.1 Growing demand for therapeutic hypothermia systems in traumatic brain injury treatment to support market growth
TABLE 73 ITALY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 74 ITALY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.3.6 SPAIN
8.3.6.1 Growing geriatric population and subsequent increase in prevalence of target conditions to drive market
TABLE 75 SPAIN: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 76 SPAIN: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.3.7 REST OF EUROPE
TABLE 77 REST OF EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 78 REST OF EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.4 ASIA PACIFIC
FIGURE 31 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SNAPSHOT
8.4.1 ASIA PACIFIC: RECESSION IMPACT
TABLE 79 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 81 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.4.2 CHINA
8.4.2.1 Increasing disposable income of middle-class population to drive market
TABLE 82 CHINA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 83 CHINA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 84 CHINA: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)
8.4.3 JAPAN
8.4.3.1 Rapidly increasing geriatric population to drive market
TABLE 85 JAPAN: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 86 JAPAN: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 87 JAPAN: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)
8.4.4 INDIA
8.4.4.1 Growing target patient population to support market growth
TABLE 88 INDIA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 89 INDIA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.4.5 REST OF ASIA PACIFIC
TABLE 90 REST OF ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 91 REST OF ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.5 REST OF THE WORLD
8.5.1 REST OF THE WORLD: RECESSION IMPACT
TABLE 92 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 93 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 94 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.5.2 LATIN AMERICA
8.5.2.1 Rising prevalence of chronic diseases to drive market
TABLE 95 LATIN AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 96 LATIN AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.5.3 MIDDLE EAST & AFRICA
8.5.3.1 High prevalence of chronic conditions to support market growth
TABLE 97 MIDDLE EAST & AFRICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 98 MIDDLE EAST & AFRICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.5.4 GCC COUNTRIES
8.5.4.1 Rise in road accident injuries and TBI to drive market
TABLE 99 GCC COUNTRIES: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 100 GCC COUNTRIES: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 STRATEGIES ADOPTED BY KEY PLAYERS
TABLE 101 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET
9.3 REVENUE ANALYSIS
FIGURE 32 REVENUE ANALYSIS FOR KEY COMPANIES IN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, 2018–2022 (USD MILLION)
9.4 MARKET SHARE ANALYSIS
FIGURE 33 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET RANKING ANALYSIS, BY KEY PLAYER (2022)
TABLE 102 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DEGREE OF COMPETITION
9.5 COMPANY EVALUATION MATRIX
9.5.1 STARS
9.5.2 EMERGING LEADERS
9.5.3 PERVASIVE PLAYERS
9.5.4 PARTICIPANTS
FIGURE 34 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: COMPANY EVALUATION MATRIX, 2022
9.5.5 COMPANY FOOTPRINT
TABLE 103 PRODUCT FOOTPRINT (11 PLAYERS)
TABLE 104 REGIONAL FOOTPRINT (11 PLAYERS)
TABLE 105 OVERALL COMPANY FOOTPRINT (11 PLAYERS)
9.6 STARTUP/SME EVALUATION MATRIX
9.6.1 PROGRESSIVE COMPANIES
9.6.2 STARTING BLOCKS
9.6.3 RESPONSIVE COMPANIES
9.6.4 DYNAMIC COMPANIES
FIGURE 35 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: STARTUP/SME EVALUATION MATRIX, 2022
9.6.5 COMPETITIVE BENCHMARKING
TABLE 106 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 107 PRODUCT & SERVICE FOOTPRINT (STARTUPS/SMES)
TABLE 108 REGIONAL FOOTPRINT (STARTUPS/SMES)
TABLE 109 OVERALL COMPANY FOOTPRINT (STARTUPS/SMES)
9.7 COMPETITIVE SCENARIO AND TRENDS
9.7.1 DEALS
TABLE 110 THERAPEUTIC HYPOTHERMIA SYSTEMS: DEALS, JANUARY 2020–NOVEMBER 2023
9.7.2 OTHER DEVELOPMENTS
TABLE 111 THERAPEUTIC HYPOTHERMIA SYSTEMS: OTHER DEVELOPMENTS, JANUARY 2020–NOVEMBER 2023
10 COMPANY PROFILES
10.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
10.1.1 ASAHI KASEI CORPORATION (ZOLL MEDICAL CORPORATION)
TABLE 112 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW
FIGURE 36 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2022)
10.1.2 BECTON, DICKINSON AND COMPANY
TABLE 113 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 37 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
10.1.3 GENTHERM INCORPORATED
TABLE 114 GENTHERM INCORPORATED: BUSINESS OVERVIEW
FIGURE 38 GENTHERM INCORPORATED: COMPANY SNAPSHOT (2022)
10.1.4 STRYKER CORPORATION
TABLE 115 STRYKER CORPORATION: BUSINESS OVERVIEW
FIGURE 39 STRYKER CORPORATION: COMPANY SNAPSHOT (2022)
10.1.5 BELMONT MEDICAL TECHNOLOGIES
TABLE 116 BELMONT MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW
10.1.6 INTERNATIONAL BIOMEDICAL LTD.
TABLE 117 INTERNATIONAL BIOMEDICAL LTD.: BUSINESS OVERVIEW
10.1.7 EM-MED
TABLE 118 EM-MED: BUSINESS OVERVIEW
10.1.8 PHOENIX MEDICAL SYSTEMS
TABLE 119 PHOENIX MEDICAL SYSTEMS: BUSINESS OVERVIEW
10.1.9 LIFE RECOVERY SYSTEMS
TABLE 120 LIFE RECOVERY SYSTEMS: BUSINESS OVERVIEW
10.1.10 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.
TABLE 121 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.: BUSINESS OVERVIEW
10.1.11 MIRACRADLE (PLUSS ADVANCED TECHNOLOGIES PVT. LTD.)
TABLE 122 MIRACRADLE: BUSINESS OVERVIEW
10.2 OTHER PLAYERS
10.2.1 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
TABLE 123 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: COMPANY OVERVIEW
10.2.2 PFM MEDICAL HICO GMBH
TABLE 124 PFM MEDICAL HICO GMBH: COMPANY OVERVIEW
10.2.3 VNG MEDICAL INNOVATION SYSTEM PVT. LTD.
TABLE 125 VNG MEDICAL INNOVATION SYSTEM PVT. LTD.: COMPANY OVERVIEW
10.2.4 ASPEN SYSTEMS
TABLE 126 ASPEN SYSTEMS: COMPANY OVERVIEW
10.2.5 COOLTECH MEDICAL
TABLE 127 COOLTECH MEDICAL: COMPANY OVERVIEW
10.2.6 GLOBAL HEALTHCARE SG
TABLE 128 GLOBAL HEALTHCARE SG: COMPANY OVERVIEW
10.2.7 CRYOTHERMIC SYSTEMS INCORPORATED
TABLE 129 CRYOTHERMIC SYSTEMS INCORPORATED: COMPANY OVERVIEW
10.2.8 PAXMAN COOLERS LTD.
TABLE 130 PAXMAN COOLERS LTD.: COMPANY OVERVIEW
10.2.9 DIGNITANA AB
TABLE 131 DIGNITANA AB: COMPANY OVERVIEW
10.2.10 WISHCAPS
TABLE 132 WISHCAPS: COMPANY OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11 APPENDIX
11.1 DISCUSSION GUIDE
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.3 CUSTOMIZATION OPTIONS
11.4 RELATED REPORTS
11.5 AUTHOR DETAILS
